Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.
Prondzynski M, Lemoine MD, Zech AT, Horváth A, Di Mauro V, Koivumäki JT, Kresin N, Busch J, Krause T, Krämer E, Schlossarek S, Spohn M, Friedrich FW, Münch J, Laufer SD, Redwood C, Volk AE, Hansen A, Mearini G, Catalucci D, Meyer C, Christ T, Patten M, Eschenhagen T, Carrier L. Prondzynski M, et al. Among authors: carrier l. EMBO Mol Med. 2022 Aug 8;14(8):e16423. doi: 10.15252/emmm.202216423. EMBO Mol Med. 2022. PMID: 35938313 Free PMC article. No abstract available.
The ubiquitin-proteasome system in cardiac dysfunction.
Mearini G, Schlossarek S, Willis MS, Carrier L. Mearini G, et al. Among authors: carrier l. Biochim Biophys Acta. 2008 Dec;1782(12):749-63. doi: 10.1016/j.bbadis.2008.06.009. Epub 2008 Jun 25. Biochim Biophys Acta. 2008. PMID: 18634872 Free article. Review.
A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy.
Friedrich FW, Bausero P, Sun Y, Treszl A, Krämer E, Juhr D, Richard P, Wegscheider K, Schwartz K, Brito D, Arbustini E, Waldenström A, Isnard R, Komajda M, Eschenhagen T, Carrier L; EUROGENE Heart Failure Project. Friedrich FW, et al. Among authors: carrier l. Eur Heart J. 2009 Jul;30(13):1648-55. doi: 10.1093/eurheartj/ehp153. Epub 2009 May 8. Eur Heart J. 2009. PMID: 19429631
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms.
Mearini G, Gedicke C, Schlossarek S, Witt CC, Krämer E, Cao P, Gomes MD, Lecker SH, Labeit S, Willis MS, Eschenhagen T, Carrier L. Mearini G, et al. Among authors: carrier l. Cardiovasc Res. 2010 Jan 15;85(2):357-66. doi: 10.1093/cvr/cvp348. Epub 2009 Oct 22. Cardiovasc Res. 2010. PMID: 19850579 Free PMC article.
The ubiquitin-proteasome system in cardiomyopathies.
Schlossarek S, Carrier L. Schlossarek S, et al. Among authors: carrier l. Curr Opin Cardiol. 2011 May;26(3):190-5. doi: 10.1097/HCO.0b013e32834598fe. Curr Opin Cardiol. 2011. PMID: 21415726 Review.
Genetics of hypertrophic and dilated cardiomyopathy.
Friedrich FW, Carrier L. Friedrich FW, et al. Among authors: carrier l. Curr Pharm Biotechnol. 2012 Oct;13(13):2467-76. doi: 10.2174/138920112804583041. Curr Pharm Biotechnol. 2012. PMID: 22280421 Review.
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.
Friedrich FW, Wilding BR, Reischmann S, Crocini C, Lang P, Charron P, Müller OJ, McGrath MJ, Vollert I, Hansen A, Linke WA, Hengstenberg C, Bonne G, Morner S, Wichter T, Madeira H, Arbustini E, Eschenhagen T, Mitchell CA, Isnard R, Carrier L. Friedrich FW, et al. Among authors: carrier l. Hum Mol Genet. 2012 Jul 15;21(14):3237-54. doi: 10.1093/hmg/dds157. Epub 2012 Apr 20. Hum Mol Genet. 2012. PMID: 22523091
254 results